Candice Andalia's move to Kirkland was highlighted in Law360.
Kirkland & Ellis LLP has snapped up a litigator from Orrick Herrington & Sutcliffe LLP who specializes in a range of areas including prescription drugs.
Candice Andalia joined Kirkland & Ellis as a Washington, D.C.-based partner, the firm said on July 6.
Andalia told Law360 in an email that she was "very grateful for the great, hands-on disputes experience [she] gained at Orrick," but that she "was drawn to Kirkland's top-tier litigation practice, global reach, commitment to fostering diverse teams, and multidisciplinary approach."
"Kirkland presents an opportunity for me to continue advising multinational companies on coordinated strategies in complex, significant class actions, and I look forward to working with the team to best position clients to serve their customers and stakeholders," she said.
Andalia got her undergraduate degree from Yale University and then went to Cornell Law School, she said.
In 2011, she started at Kaye Scholer, but she later decided to clerk for Judge Andrew L. Carter in the U.S. District Court for the Southern District of New York to get more court experience, she said.
Andalia said that she left Orrick Herrington & Sutcliffe as a complex litigation and dispute resolution senior associate, having represented clients in the biotechnology realm and other fields.
Andalia's client base includes those in the technology and financial services fields as well as manufacturers of things like biologics and pharmaceuticals, she said.
"Since studying bioethics at Yale, I've been interested in the interstices of law and science, especially where the biological and technological landscape advances by leaps and bounds ahead of existing legal frameworks," she said. "This disconnect creates opportunities to work on issues of first impression and to find creative solutions for clients in scientific industries focused on improving our collective quality of life."
She said that her practice involves guiding clients on things like class actions, arbitration and mass tort cases. She added that she has a well-rounded practice, having dealt with white collar issues and corruption matters.
Andalia said that the work that she does, "which often runs the gamut from therapeutics to machine learning to artificial intelligence, offers an extremely diverse practice for a litigator."
"I can't think of a finer litigation team than Kirkland's to continue the work of finding creative solutions that reflect the innovative nature of our life sciences and technology clients," she said.